-+ 0.00%
-+ 0.00%
-+ 0.00%

SIMCERE PHARMACEUTICAL - UNDER DEAL NEXTCURE TO OBTAIN GLOBAL RIGHTS TO SIM0505 NOVEL ANTIBODY-DRUG CONJUGATE, OTHERS

Reuters·06/16/2025 11:05:50

Please log in to view news